Cardiology
GLP-1 Drugs Halve Cardiac Risk
AI द्वारा रिपोर्ट किया गया
Recent research showed that GLP-1 receptor agonists reduce cardiac event risks by half in certain patient groups. This finding supports expanded use of these drugs beyond diabetes management. The study contributes to ongoing discussions in cardiovascular medicine.
PCI volumes in US hospitals declined in 2022
AI द्वारा रिपोर्ट किया गया
After a surge during the COVID-19 pandemic, percutaneous coronary intervention (PCI) procedure volumes in U.S. hospitals dropped by about 5% in 2022 compared to the previous year. Data from the American College of Cardiology's CathPCI Registry highlights this trend, reflecting ongoing recovery challenges in cardiology care. Experts attribute the decline to lingering effects of the pandemic on patient volumes and procedural backlogs.
Immune protein promotes arrhythmias after heart attacks
Researchers at Massachusetts General Hospital have identified an immune protein that damages heart cells after a myocardial infarction, leading to dangerous arrhythmias. By targeting this protein in mice, the team reduced arrhythmia incidents twelvefold. The findings suggest new ways to prevent sudden cardiac death.
Baxdrostat Effective for Hypertension
A new study revealed that Baxdrostat significantly reduces blood pressure in patients with resistant hypertension. The findings challenge existing treatments and suggest a new option for managing this condition. Results were highlighted as part of recent medical advancements.